Seattle biotech firm Shape Therapeutics inks gene therapy deal

Shape Therapeutics has signed a deal potentially exceeding $3 billion with pharma giant Roche to support the development of gene therapies for Alzheimer’s

Fierce Biotech Fundraising Tracker 2024

CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells

Gene therapy finds its niche

Seattle biotech firm Shape Therapeutics inks gene therapy deal

Shape Therapeutics, Inc. Raises $35.5M Series A Financing, Led by

Seattle startup Cyrus inks protein-design deal with immune biotech

Shape Therapeutics Inc.

Fierce Biotech's 2022 Fierce 15

Shape Therapeutics Inc.

Gene therapies may cure disease but can we afford them?